Latest action: Referred to the House Committee on Energy and Commerce.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Promotes early detection and screening programs for colorectal cancer across the United States.
The problem
Colorectal cancer remains a leading cause of cancer deaths. Many Americans don't get recommended screenings due to cost, awareness, or access barriers.
The proposal
The bill likely establishes or expands colorectal cancer screening programs, improves access to early detection services, and increases public awareness about screening importance.
The impact
Patients gain better access to cancer screening. Healthcare providers implement new screening programs. Insurance systems may cover additional screening costs.
Early screening catches colorectal cancer at treatable stages, significantly improving survival rates and patient outcomes. Detecting cancer early is less expensive and invasive than treating advanced disease.
Preventing advanced cancer cases reduces expensive emergency treatments and hospitalizations. Early detection costs less overall than treating late-stage cancer.
The bill likely funds education campaigns about cancer risks and screening benefits. Better awareness helps more people make informed health decisions.
Programs can target rural and low-income populations with limited screening access. More equitable healthcare delivery improves health outcomes across demographic groups.
New screening programs require federal funding allocation. Budget constraints may limit program scope or require cuts elsewhere.
Healthcare systems may lack capacity or resources to quickly implement new screening programs. Training staff and acquiring equipment takes time and money.
Increased screening can lead to more false positive results, causing unnecessary patient anxiety and follow-up procedures. Not all screening findings indicate actual cancer.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.